-
公开(公告)号：US20160256555A1
公开(公告)日：2016-09-08
申请号：US15156922
申请日：2016-05-17
申请人： OCTAPHARMA AG
CPC分类号： A61K47/26 , A61K9/0019 , A61K9/19 , A61K38/193 , A61K38/37 , A61K38/4846 , C07K14/535 , C07K14/745 , C07K14/755 , C12N9/644 , C12N9/647 , C12N9/96 , C12Y304/21022
摘要： A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
摘要翻译： 一种通过在分子量> 10KDa的包含人血液蛋白质或人血浆蛋白质的溶液中加入乐曲霉来稳定分子量> 10KDa的人血液蛋白质或人血浆蛋白质的方法。
-
公开(公告)号：US10098956B2
公开(公告)日：2018-10-16
申请号：US15156922
申请日：2016-05-17
申请人： OCTAPHARMA AG
IPC分类号： A61K38/48 , A61K47/26 , A61K38/19 , A61K9/19 , A61K38/37 , A61K9/00 , C07K14/535 , C07K14/755 , C12N9/64 , C12N9/96 , C07K14/745
摘要： A method for stabilizing a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
-
公开(公告)号：US20140221290A1
公开(公告)日：2014-08-07
申请号：US14245252
申请日：2014-04-04
申请人： OCTAPHARMA AG
CPC分类号： A61K47/26 , A61K9/0019 , A61K9/19 , A61K38/193 , A61K38/37 , A61K38/4846 , C07K14/535 , C07K14/745 , C07K14/755 , C12N9/644 , C12N9/647 , C12N9/96 , C12Y304/21022
摘要： A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
摘要翻译： 一种通过在分子量> 10KDa的包含人血液蛋白质或人血浆蛋白质的溶液中加入乐曲霉来稳定分子量> 10KDa的人血液蛋白质或人血浆蛋白质的方法。
-
公开(公告)号：US20190030169A1
公开(公告)日：2019-01-31
申请号：US16145040
申请日：2018-09-27
申请人： OCTAPHARMA AG
IPC分类号： A61K47/26 , C07K14/745 , A61K38/48 , A61K38/19 , A61K38/37 , C12N9/96 , A61K9/00 , C12N9/64 , C07K14/755 , C07K14/535 , A61K9/19
摘要： A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
-
公开(公告)号：US09943600B2
公开(公告)日：2018-04-17
申请号：US14245252
申请日：2014-04-04
申请人： OCTAPHARMA AG
IPC分类号： A61K38/37 , A61K47/26 , A61K9/00 , A61K9/19 , C07K14/535 , C07K14/755 , C12N9/64 , C12N9/96 , C07K14/745 , A61K38/19 , A61K38/48
CPC分类号： A61K47/26 , A61K9/0019 , A61K9/19 , A61K38/193 , A61K38/37 , A61K38/4846 , C07K14/535 , C07K14/745 , C07K14/755 , C12N9/644 , C12N9/647 , C12N9/96 , C12Y304/21022
摘要： A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
-
-
-
-
搜索结果
5 条记录 (耗时 0.011 秒)
